NIH should involve the not-yet-funded in review

Following up my post on RFAs and the inherent self-reinforcing conservatism of NIH grant review.

But I also advocate NIH review participation of the not-yet-funded for this very reason. @MTomasson

— Drug Monkey (@drugmonkeyblog) November 9, 2015